Universal Health Services, Inc.
UHS · NYSE
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 13.40B | 11.93B | 1.00B | 675.61M | 9.23 |
| 2023 FY | 14.28B | 12.75B | 1.18B | 717.80M | 10.35 |
| 2024 FY | 15.83B | 14.24B | 1.68B | 1.14B | 17.16 |
| 2025 FY | 17.36B | 15.71B | 1.99B | 1.49B | 23.42 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 13.49B | 7.52B | 102.82M | 5.27B | 5.92B |
| 2023 FY | 13.97B | 7.77B | 119.44M | 5.37B | 6.15B |
| 2024 FY | 14.47B | 7.71B | 125.98M | 4.96B | 6.67B |
| 2025 FY | 15.96B | 8.55B | 137.80M | 5.51B | 7.28B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 996.02M | -734.00M | 262.02M | -58.45M | 21.90M |
| 2023 FY | 1.27B | -743.06M | 524.74M | -55.48M | 13.63M |
| 2024 FY | 2.07B | -943.81M | 1.12B | -53.35M | 10.28M |
| 2025 FY | 1.86B | -1.02B | 849.25M | -51.27M | 46.57M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 10.30B | 15.47B | — | — | — |
| 2023 FY | 10.57B | 15.81B | — | — | — |
| 2024 FY | 11.94B | 16.77B | — | — | — |
| 2025 FY | 13.86B | 19.23B | — | — | — |
| 2026-12-31 | — | — | — | — | — |
| 2027-12-31 | — | — | — | — | — |
| 2028-12-31 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 4.28B | 3.87B | 500.27M | 353.22M | 5.49 |
| 2025 Q3 | 4.50B | 4.08B | 521.69M | 372.96M | 5.80 |
| 2025 Q4 | 4.49B | 4.06B | 517.23M | 445.94M | 7.14 |
| 2026 Q1 | 4.50B | 658.29M | 502.86M | 348.68M | 5.71 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 14.99B | 7.84B | 137.60M | 5.01B | 7.03B |
| 2025 Q3 | 15.34B | 8.05B | 112.90M | 5.11B | 7.23B |
| 2025 Q4 | 15.96B | 8.55B | 137.80M | 5.51B | 7.28B |
| 2026 Q1 | 15.68B | 8.11B | 119.03M | 5.13B | 7.53B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 548.98M | -266.01M | 282.96M | -12.90M | 17.67M |
| 2025 Q3 | 380.68M | -247.57M | 133.11M | -12.47M | -24.80M |
| 2025 Q4 | 574.69M | -281.22M | 293.47M | -12.37M | 24.90M |
| 2026 Q1 | 401.63M | -217.16M | 184.47M | -12.97M | -18.77M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 11.66B | 16.53B | — | — | — |
| 2025 Q3 | 13.16B | 18.15B | — | — | — |
| 2025 Q4 | 13.86B | 19.23B | — | — | — |
| 2026 Q1 | 10.93B | 15.94B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |